97022 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin; Melanocyte-stimulating hormone [MSH] Alpha-melanotropin
COMPOSITIONS FOR THE TREATMENT OF DISEASE
#2METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
#3PEPTIDE COMPOSITIONS
#4Cyclic peptide analogs of melanocortin and amanitin and methods of making such
#5ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF
#6METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
#7Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
#8Method of treating melanocortin-4 receptor pathway-associated disorders
#9Peptide compositions
#10Cyclic peptide analogs of melanocortin and amanitin and methods of making such
#11Pharmaceutical compound
#12Modulators of melanocortin receptors
#13Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#14Melanocortin receptor-specific peptides
#15Peptide compositions
#16Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
#17ENGINEERED NUCLEIC ACIDS AND METHODS OF USE THEREOF
#18Fusion protein for alpha-melanocyte stimulating hormone and preparation method and use thereof
#19Compositions and methods for treating central nervous system (CNS) disorders and mood disorders
#20Method of treating melanocortin-4 receptor pathway-associated disorders
#21Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
#22METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
#23Enhanced melanoma cancer prevention by novel melanotropins
#24Nucleic acid construct
#25Pharmaceutical compound
#26Therapy for vitiligo
#27Peptide analogs of alpha-melanocyte stimulating hormone
#28Alpha- and gamma-MSH analogues
#29Methods for the treatment of depression and anxiety
#30Methods for the treatment of central nervous system (CNS) disorders and mood disorders
#31Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#32Melanocortin receptor-specific peptides
#33Melanotropin ligands for skin care
#34Alpha-and gamma-MSH analogues
#35Peptide analogs of alpha-melanocyte stimulating hormone
#36Engineered nucleic acids and methods of use thereof
#37Peptide compositions
#38Method for delivering alpha-melanocyte stimulating hormone mimetibody composition comprising propylene glycol for intranasal administration to the central nervous system
#39Melanocortin receptor-specific heptapeptides
#40Alpha- and gamma-MSH analogues
#41Compounds for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#42Peptide analogs of alpha-melanocyte stimulating hormone
#43Method for preventing or reducing acute renal failure by administration of therapeutically active α-MSH analogues
#44Process for the Synthesis of Ac-Arg-Cyclo(Cys-D-Ala-His-D-Phe-Arg-Trp-Cys)-NH2
#45Melanocortin receptor-specific peptides
#46Lactam-bridged melanocortin receptor-specific peptides
#47Engineered nucleic acids and methods of use thereof
#48Peptides for Treatment of Obesity
#49PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS
#50THERAPY FOR VITILIGO
#51Intranasal administration of active agents to the central nervous system
#52Melanocortin receptor-specific peptides for treatment of sexual dysfunction
#53Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#54Fusion proteins of alpha-MSH derivatives and Fc
#55Peptides for Treatment of Obesity
#56CYCLIC PEPTIDE MELANOCORTIN RECEPTOR LIGANDS
#57Cyclic peptide compositions for treatment of sexual dysfunction
#58Chelating agent conjugated α-MSH peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient
#59Peptide analogs of alpha-melanocyte stimulating hormone
#60Ligands of melanocortin receptors
#61Novel Peptides for Use in the Treatment of Obesity
#62Intranasal Administration of Active Agents to the Central Nervous System
#63Therapeutically active alpha MSH analogues
#64Bifunctional hormone having alpha-MSH activity and natriuretic peptide activity and uses thereof
#65Backbone Cyclized Melanocortin Stimulating Hormone (Alpha Msh) Analogs
#66Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#67Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#68Peptide Cyclisation
#69Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#70Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#71Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#72N and/or N derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH)(CO)] by coordination
#73Melanocortin 1 receptor selective compounds
#74Alpha-MSH related compounds and methods of use
#75Cyclic peptide compositions for treatment of sexual dysfunction
#76Transglutaminase linkage of agents to tissue
#77Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
#78Methods of treating bladder disorders
#79α-MSH related compounds and methods of use
#80Multiple agent therapy for sexual dysfunction
#81Use of KPV tripeptide for dermatological disorders
#82Composition and methods for treatment of sexual dysfunction
#83Octapeptide bombesin analogs
#84Sunburn treatment and sunburn prevention method